Recently, glial fibrillary acidic protein (GFAP), an intermediate filament found in astrocytes, and especially neurofilament light chains (NfL), an important structural protein found in neurons, have emerged as promising biomarkers for HE in patients with cirrhosis [9, 10]. This evidence concerns the gene GFAP and Cirrhosis.